FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2901179619> ?p ?o ?g. }

• W2901179619 abstract "Natural-killer/T-cell lymphoma (NKTL) is a rare subset of non-Hodgkin lymphoma that demonstrates a unique geographic distribution, with higher prevalence in Asia compared to the West1. While cure remains achievable in early-stage disease, the prognosis for advanced-stage NKTL is dismal2. Recently, some progress has been made in uncovering the molecular pathogenesis of NKTL. In a genome-wide association study, strong correlations between HLA-DPB1 single-nucleotide polymorphisms and NKTL susceptibility were discovered, implicating altered antigen processing and presentation to CD4-positive T-lymphocytes in this Epstein-Barr virus (EBV)-associated malignancy3. Next generation sequencing also revealed recurrent somatic mutations such as TP53, JAK3, STAT3 and DDX3X in NKTL4,5. In this paper, we report a pair of male siblings from a non-consanguineous Chinese family who were diagnosed with NKTL, and provide initial evidence for novel recessive germline mutations in FAM160A1 identified through next-generation sequencing.The index patient was 35 years old, when he presented with nasal blockage in March 2013. 18-FDG-PET/CT imaging revealed an 18-FDG-avid nasal mass infiltrating into the palate, as well as enlarged cervical lymph nodes. Biopsy of the mass showed abnormal lymphoid cells positive for CD56 by immunohistochemistry (IHC) as well as EBV-encoded RNA (EBER) by in-situ hybridization. He was diagnosed with stage IIA extranodal NKTL, nasal type, and treated with 4 cycles of bortezomib-GIFOX (gemcitabine, ifosfamide and oxaliplatin) as part of a clinical trial followed by radiotherapy to the nasal region. He had primary-refractory disease and was further treated with 4 cycles of SMILE (dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide) followed by high-dose chemotherapy and autologous stem cell transplantation. He progressed and received ruxolitinib off-label, followed by RAD001 (mTOR inhibitor) and LBH589B (histone deacetylase inhibitor) as part of another clinical trial. He then had radiotherapy to an ulcerating penile lesion before he died of progressive disease 27 months after diagnosis (Supplementary Table 1).His younger brother was 18 years old, when diagnosed with NKTL affecting the nasal floor in 1998 following a bout of epistaxis. He received 6 cycles of CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) with high-dose methotrexate and went into complete remission. Three years later he was diagnosed with chronic myeloid leukemia, for which he received hydroxyurea. In 2004, he had a relapse of NKTL and received ESHAP (etoposide, prednisolone, cytarabine and cisplatin), total body irradiation and allogeneic bone marrow transplant. He died of transplant-related complications 6 years from diagnosis. These siblings have an older brother unaffected by any hematological malignancy. Their father died of a non-malignant condition in his fifties and their mother remains well at the age of 68 years. Among their first-degree relatives, none were known to be inflicted with hematologic malignancies (Fig. ​(Fig.11).Open in a separate windowFig. 1Clinical characterization of brothers with familial NKTL.a 18-FDG-PET/CT image depicting a large nasal mass infiltrating into the palate, of which biopsy showed abnormal lymphoid cells positive for Epstein-Barr virus encoded RNA (EBER) by in situ hybridization. b, c Inheritance modelling identified homozygous germline mutations of FAM160A1 c.2827 C > T in both affected brothers, heterozygous carriage in their mother and paternal aunt, and homozygous wildtype in their healthy older brother. d, e The non-synonymous substitution at FAM160A1 c.2827 C > T results in an amino-acid alteration from arginine to cysteine (p.R943C). Patterns and frequencies of known mutations in other cancer types are shown" @default.
• W2901179619 created "2018-11-29" @default.
• W2901179619 creator A5003897048 @default.
• W2901179619 creator A5011599008 @default.
• W2901179619 creator A5011817862 @default.
• W2901179619 creator A5014023096 @default.
• W2901179619 creator A5014643846 @default.
• W2901179619 creator A5017643653 @default.
• W2901179619 creator A5020283356 @default.
• W2901179619 creator A5026320292 @default.
• W2901179619 creator A5028165330 @default.
• W2901179619 creator A5032292277 @default.
• W2901179619 creator A5036352547 @default.
• W2901179619 creator A5036602508 @default.
• W2901179619 creator A5038667383 @default.
• W2901179619 creator A5039741374 @default.
• W2901179619 creator A5041351570 @default.
• W2901179619 creator A5044506875 @default.
• W2901179619 creator A5049476321 @default.
• W2901179619 creator A5055376683 @default.
• W2901179619 creator A5062854999 @default.
• W2901179619 creator A5064775390 @default.
• W2901179619 creator A5073065181 @default.
• W2901179619 creator A5078299643 @default.
• W2901179619 creator A5080242763 @default.
• W2901179619 creator A5080651917 @default.
• W2901179619 creator A5081219793 @default.
• W2901179619 creator A5083776263 @default.
• W2901179619 creator A5085167346 @default.
• W2901179619 creator A5085639508 @default.
• W2901179619 creator A5087446798 @default.
• W2901179619 date "2018-11-12" @default.
• W2901179619 modified "2023-10-12" @default.
• W2901179619 title "Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK/T cell lymphoma" @default.
• W2901179619 cites W1611787727 @default.
• W2901179619 cites W1992791895 @default.
• W2901179619 cites W2085018166 @default.
• W2901179619 cites W2103017472 @default.
• W2901179619 cites W2129797485 @default.
• W2901179619 cites W2149441684 @default.
• W2901179619 cites W2152487909 @default.
• W2901179619 cites W2160289258 @default.
• W2901179619 cites W2190030883 @default.
• W2901179619 cites W2494220216 @default.
• W2901179619 cites W2726349956 @default.
• W2901179619 cites W977201031 @default.
• W2901179619 doi "https://doi.org/10.1038/s41408-018-0149-5" @default.
• W2901179619 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6232147" @default.
• W2901179619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30420729" @default.
• W2901179619 hasPublicationYear "2018" @default.
• W2901179619 type Work @default.
• W2901179619 sameAs 2901179619 @default.
• W2901179619 citedByCount "5" @default.
• W2901179619 countsByYear W29011796192019 @default.
• W2901179619 countsByYear W29011796192021 @default.
• W2901179619 crossrefType "journal-article" @default.
• W2901179619 hasAuthorship W2901179619A5003897048 @default.
• W2901179619 hasAuthorship W2901179619A5011599008 @default.
• W2901179619 hasAuthorship W2901179619A5011817862 @default.
• W2901179619 hasAuthorship W2901179619A5014023096 @default.
• W2901179619 hasAuthorship W2901179619A5014643846 @default.
• W2901179619 hasAuthorship W2901179619A5017643653 @default.
• W2901179619 hasAuthorship W2901179619A5020283356 @default.
• W2901179619 hasAuthorship W2901179619A5026320292 @default.
• W2901179619 hasAuthorship W2901179619A5028165330 @default.
• W2901179619 hasAuthorship W2901179619A5032292277 @default.
• W2901179619 hasAuthorship W2901179619A5036352547 @default.
• W2901179619 hasAuthorship W2901179619A5036602508 @default.
• W2901179619 hasAuthorship W2901179619A5038667383 @default.
• W2901179619 hasAuthorship W2901179619A5039741374 @default.
• W2901179619 hasAuthorship W2901179619A5041351570 @default.
• W2901179619 hasAuthorship W2901179619A5044506875 @default.
• W2901179619 hasAuthorship W2901179619A5049476321 @default.
• W2901179619 hasAuthorship W2901179619A5055376683 @default.
• W2901179619 hasAuthorship W2901179619A5062854999 @default.
• W2901179619 hasAuthorship W2901179619A5064775390 @default.
• W2901179619 hasAuthorship W2901179619A5073065181 @default.
• W2901179619 hasAuthorship W2901179619A5078299643 @default.
• W2901179619 hasAuthorship W2901179619A5080242763 @default.
• W2901179619 hasAuthorship W2901179619A5080651917 @default.
• W2901179619 hasAuthorship W2901179619A5081219793 @default.
• W2901179619 hasAuthorship W2901179619A5083776263 @default.
• W2901179619 hasAuthorship W2901179619A5085167346 @default.
• W2901179619 hasAuthorship W2901179619A5085639508 @default.
• W2901179619 hasAuthorship W2901179619A5087446798 @default.
• W2901179619 hasBestOaLocation W29011796191 @default.
• W2901179619 hasConcept C104317684 @default.
• W2901179619 hasConcept C10590036 @default.
• W2901179619 hasConcept C109825262 @default.
• W2901179619 hasConcept C13514818 @default.
• W2901179619 hasConcept C16671776 @default.
• W2901179619 hasConcept C203014093 @default.
• W2901179619 hasConcept C2779338263 @default.
• W2901179619 hasConcept C47042493 @default.
• W2901179619 hasConcept C501734568 @default.
• W2901179619 hasConcept C502942594 @default.
• W2901179619 hasConcept C54355233 @default.
• W2901179619 hasConcept C71924100 @default.
• W2901179619 hasConcept C86803240 @default.
• W2901179619 hasConceptScore W2901179619C104317684 @default.

• next